View in EDS

Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.
Authors: Rumyantsev A; Vaxxinity, Inc., FL, USA., Wang L; Vaxxinity, Inc., FL, USA., Wang S; Vaxxinity, Inc., FL, USA., Kemp T; Vaxxinity, Inc., FL, USA., Wriggins A; Vaxxinity, Inc., FL, USA., Burks A; Vaxxinity, Inc., FL, USA., Fisher D; Vaxxinity, Inc., FL, USA., Brokke K; Vaxxinity, Inc., FL, USA., Fix A; Vaxxinity, Inc., FL, USA., Hensley S; Vaxxinity, Inc., FL, USA., Lewis M; Vaxxinity, Inc., FL, USA., Zhu R; AvanSight, Inc., CA, USA., Wang K; AvanSight, Inc., CA, USA., Shasha C; AvanSight, Inc., CA, USA., Piccini G; VisMederi srl, Siena, Italy., Manenti A; VisMederi srl, Siena, Italy., Montomoli E; VisMederi srl, Siena, Italy., DeAntonio R; Cevaxin, Panama City, Panama., Saez-Llorens X; Cevaxin, Panama City, Panama., Chan M; Cevaxin, Panama City, Panama., Alberto E; Health Index Multispecialty Clinic, Bacoor, Philippines., Lallaine Borra MD; St. Pauls Hospital, Iloilo, Philippines., Jaen AM; Iloilo Doctor's Hospital, Iloilo, Philippines., Heppner G; Vaxxinity, Inc., FL, USA., Palm U; Vaxxinity, Inc., FL, USA., Monath TP; Vaxxinity, Inc., FL, USA.
Source: EClinicalMedicine [EClinicalMedicine] 2025 Jul 21; Vol. 86, pp. 103349. Date of Electronic Publication: 2025 Jul 21 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40727012
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rumyantsev+A%22">Rumyantsev A</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Kemp+T%22">Kemp T</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Wriggins+A%22">Wriggins A</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Burks+A%22">Burks A</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Fisher+D%22">Fisher D</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Brokke+K%22">Brokke K</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Fix+A%22">Fix A</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Hensley+S%22">Hensley S</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Lewis+M%22">Lewis M</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+R%22">Zhu R</searchLink>; AvanSight, Inc., CA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; AvanSight, Inc., CA, USA.<br /><searchLink fieldCode="AU" term="%22Shasha+C%22">Shasha C</searchLink>; AvanSight, Inc., CA, USA.<br /><searchLink fieldCode="AU" term="%22Piccini+G%22">Piccini G</searchLink>; VisMederi srl, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Manenti+A%22">Manenti A</searchLink>; VisMederi srl, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Montomoli+E%22">Montomoli E</searchLink>; VisMederi srl, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22DeAntonio+R%22">DeAntonio R</searchLink>; Cevaxin, Panama City, Panama.<br /><searchLink fieldCode="AU" term="%22Saez-Llorens+X%22">Saez-Llorens X</searchLink>; Cevaxin, Panama City, Panama.<br /><searchLink fieldCode="AU" term="%22Chan+M%22">Chan M</searchLink>; Cevaxin, Panama City, Panama.<br /><searchLink fieldCode="AU" term="%22Alberto+E%22">Alberto E</searchLink>; Health Index Multispecialty Clinic, Bacoor, Philippines.<br /><searchLink fieldCode="AU" term="%22Lallaine+Borra+MD%22">Lallaine Borra MD</searchLink>; St. Pauls Hospital, Iloilo, Philippines.<br /><searchLink fieldCode="AU" term="%22Jaen+AM%22">Jaen AM</searchLink>; Iloilo Doctor's Hospital, Iloilo, Philippines.<br /><searchLink fieldCode="AU" term="%22Heppner+G%22">Heppner G</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Palm+U%22">Palm U</searchLink>; Vaxxinity, Inc., FL, USA.<br /><searchLink fieldCode="AU" term="%22Monath+TP%22">Monath TP</searchLink>; Vaxxinity, Inc., FL, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2025 Jul 21; Vol. 86, pp. 103349. <i>Date of Electronic Publication: </i>2025 Jul 21 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40727012
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.eclinm.2025.103349
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 103349
    Titles:
      – TitleFull: Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rumyantsev A
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Kemp T
      – PersonEntity:
          Name:
            NameFull: Wriggins A
      – PersonEntity:
          Name:
            NameFull: Burks A
      – PersonEntity:
          Name:
            NameFull: Fisher D
      – PersonEntity:
          Name:
            NameFull: Brokke K
      – PersonEntity:
          Name:
            NameFull: Fix A
      – PersonEntity:
          Name:
            NameFull: Hensley S
      – PersonEntity:
          Name:
            NameFull: Lewis M
      – PersonEntity:
          Name:
            NameFull: Zhu R
      – PersonEntity:
          Name:
            NameFull: Wang K
      – PersonEntity:
          Name:
            NameFull: Shasha C
      – PersonEntity:
          Name:
            NameFull: Piccini G
      – PersonEntity:
          Name:
            NameFull: Manenti A
      – PersonEntity:
          Name:
            NameFull: Montomoli E
      – PersonEntity:
          Name:
            NameFull: DeAntonio R
      – PersonEntity:
          Name:
            NameFull: Saez-Llorens X
      – PersonEntity:
          Name:
            NameFull: Chan M
      – PersonEntity:
          Name:
            NameFull: Alberto E
      – PersonEntity:
          Name:
            NameFull: Lallaine Borra MD
      – PersonEntity:
          Name:
            NameFull: Jaen AM
      – PersonEntity:
          Name:
            NameFull: Heppner G
      – PersonEntity:
          Name:
            NameFull: Palm U
      – PersonEntity:
          Name:
            NameFull: Monath TP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 07
              Text: 2025 Jul 21
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2589-5370
          Numbering:
            – Type: volume
              Value: 86
          Titles:
            – TitleFull: EClinicalMedicine
              Type: main
ResultId 1